Celldex Announces Upcoming Presentation at the 2014 Leerink Global Healthcare Conference

        Print
| Source: Celldex Therapeutics, Inc.

HAMPTON, N.J., Feb. 6, 2014 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) announced today that Anthony Marucci, President and Chief Executive Officer, and Tom Davis, M.D., Senior Vice President and Chief Medical Officer, are scheduled to present a corporate overview at the 2014 Leerink Global Healthcare Conference on Wednesday, February 12, 2014 at 2:40 pm ET at the Waldorf Astoria in New York City.

A live webcast of the presentation will be available online on the "Events & Presentations" page of the "Investors & Media" section of the Celldex website. A replay of the presentation will be available for 30 days following the event.

About Celldex Therapeutics, Inc.

Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response. Visit www.celldex.com.

Sarah Cavanaugh
Vice President of Investor Relations &
Corp Communications
Celldex Therapeutics, Inc.
(781) 433-3161